©2018 Graphical Research. All rights reserved. North America Cell Line Development Market share to Surpass $2.7 Bn by 2024: Graphical Research

©2018 Graphical Research. All rights reserved. Key Insights from North America Cell Line Development Market:  Graphical Research, Inc. says, North America Cell Line Development Market size is set to exceed USD 2.7 billion by  Growing demand for monoclonal antibodies, technological advancements in cell line development equipment and growing number of cancer incidences will drive North America cell line development market.  Rising vaccine production, growth of biotechnology industry and high healthcare expenditure will drive business growth.  Hybridomas cell line type segment is forecasted to witness robust growth during the forecast timeframe.  Growing awareness about cell-based therapy, innovation in development of biologics and rising prevalence of cancer will stimulate growth of Canada cell line development market.

©2018 Graphical Research. All rights reserved. Continued...  Key industry players operating in North America cell line development market are Selexis, Sartorius, Lonza Group, Samsung Biologics, WuXi AppTec, GE Healthcare, Thermo Fisher Scientific, The European Collection of Cell Cultures, Sigma-Aldrich (Merck), GVK BIO, and Progenitor Cell Therapy.  Industry players are adopting strategies including merger, acquisition and strategic collaboration and partnership to expand their product portfolio as well as augment consumer base in the industry.

©2018 Graphical Research. All rights reserved. U.S. Cell Line Development Market, By Product, 2013 – 2024 (USD Bn)

©2018 Graphical Research. All rights reserved. Browse Full Market Research Report On North America Cell Line Development Request for a Sample of this Research

©2018 Graphical Research. All rights reserved. Website: Social Media: Assured Quality Industry Experts On-Time Delivery Payment Security Stay In Touch With Us For: